Document:

Exhibit 10.1

 

 

SPONSOR LETTER AGREEMENT

 

This SPONSOR LETTER
AGREEMENT (this “Agreement”), dated as of February 4, 2021, is made and entered into by and among 23andMe, VGAC,
Credit Suisse as representative of the several Underwriters, Sponsor, the Insiders and the Holders (as each such term is defined
below, together, each individually a “Party and collectively the “Parties”), in respect of and
in reference to:

 

(A)    that
certain Underwriting Agreement dated October 1, 2020 (the “Underwriting Agreement”), between VG
Acquisition Corp., a Cayman Islands exempted company (“VGAC”),
and Credit Suisse Securities (USA) LLC, a Delaware limited liability company (“Credit Suisse”), as representative
of the several Underwriters named in Schedule 1 thereto (the “Underwriters”);

 

(B)    that
certain Letter Agreement dated October 1, 2020 (the “Insider Letter”) among VGAC, VG Acquisition Sponsor LLC,
a Cayman Islands limited liability company (“Sponsor”) and each of the Insiders (as such term is defined therein,
the “Insiders”);

 

(C)    that
certain Warrant Agreement dated October 1, 2020 (the “Warrant Agreement”), between VGAC and Continental Stock
Transfer & Trust Company, a New York corporation, as warrant agent (“Warrant Agent”); and

 

(D)    that
certain Registration Rights Agreement dated October 1, 2020 (the “Registration Rights Agreement”) by and among
VGAC, Sponsor and each of the other Holders (as such term is defined therein, together with Sponsor, the “Holders”).

 

RECITALS

 

WHEREAS, contemporaneously
with the execution and delivery of this Agreement, VGAC, 23andMe, Inc., a Delaware corporation (“23andMe”),
and certain other persons party thereto, have entered into an Agreement and Plan of Merger (as amended or modified from time to
time, the “Transaction Agreement”) whereby the parties thereto intend to effect a business combination between
VGAC and 23andMe, on the terms and subject to the conditions set forth therein (collectively, the “Transactions”),
including the domestication of VGAC into Delaware as a corporation organized under the laws of the State of Delaware (the “Continuing
Delaware Corporation”) pursuant to Section 388 of the Delaware General Corporation Law (the “Domestication”);

 

WHEREAS, as of the
date hereof, Sponsor, each Insider and each Holder, in its respective capacity as such, is the holder of record and the “beneficial
owner” (within the meaning of Rule 13d-3 under the Exchange Act) of (i) the number of Class A ordinary shares, par value
$0.0001, of the Company (“Class A Shares”) set forth on Exhibit A attached hereto opposite such person’s
name on such Exhibit, (ii) private placement warrants (the “Warrants”) to purchase an aggregate number of Class
A Shares set forth on Exhibit A attached hereto opposite such person’s name on such Exhibit, and (iii) the number
of Class B ordinary shares, par value $0.0001, of the Company (“Class B Shares”) set forth on Exhibit A
attached hereto opposite such person’s name on such Exhibit;

 

     

     

    

WHEREAS, as part of
the Transactions, effective as of and contingent upon the Domestication (as such term is defined in the Transaction Agreement),
each of the Class A Shares and Class B Shares will be converted, by operation of law, into the same number of shares of Class A
Common Stock, par value $0.0001, of the Continuing Delaware Corporation (“Class A Common Stock”); and

 

WHEREAS, each of the
Parties desires to enter into and deliver this Agreement to facilitate the Transactions and the business combination to be effected
thereby, and to clarify and to the extent applicable waive or amend certain provisions of each of the Underwriting Agreement, the
Warrant Agreement, the Insider Letter and the Registration Rights Agreement (together, the “Affected Agreements”),
in each case on the terms and subject to the conditions herein.

 

AGREEMENT

 

NOW, THEREFORE, in
consideration of the foregoing and the mutual agreements contained herein, and intending to be legally bound hereby, the Parties
hereby agree (as applicable to such Party) as follows:

 

1.    Underwriting
Agreement. VGAC and Credit Suisse, on its own behalf and as representative of the several Underwriters, hereby agree as follows:

 

(a)    The
Underwriting Agreement provides for certain representations and warranties and agreements in relation to Ordinary Shares, Founders
Shares and the Amended and Restated Memorandum and Articles of Association (as such terms are defined in the Underwriting Agreement).
From and after the time and date of the Domestication, such terms shall be deemed to refer to the Class A Common Stock and the
certificate of incorporation and bylaws of the Continuing Delaware Corporation adopted in connection with the Domestication, respectively.
In furtherance thereof, the Domestication, and the conversion of the Class A Shares and Class B Shares into Class A Common Stock,
respectively, and the listing and registration of the Class A Common Stock in connection therewith, is hereby expressly permitted
and agreed to by the parties to the Underwriting Agreement, including for purposes of Sections 6(h), 6(k) and 6(aa) of the Underwriting
Agreement. For the avoidance of doubt, the representations and warranties and agreements of VGAC set forth in the Underwriting
Agreement shall survive the Domestication and continue to be binding upon the Continuing Delaware Corporation, provided that the
veracity of any representations and warranties shall only be measured as of the date of consummation of the Offering, and are not
continuing representations and warranties.

 

(b)    From
and after the Effective Time (as such term is defined in the Transaction Agreement), all communications under the Underwriting
Agreement sent VGAC (as “the Company” thereunder) shall be delivered to:

 

23andMe Holdings Co

Attention: Chief Legal and Regulatory Officer

223 N. Mathilda Ave.

Sunnyvale, CA 94086

 

    2 

     

    

With a copy to:

 

Morgan, Lewis & Bockius LLP

Attention: Marlee S. Myers and Howard A. Kenny

101 Park Ave., New York, NY 10178-0060

 

2.    Insider
Letter. VGAC, Sponsor and each Insider hereby agree as follows (and Credit Suisse, on its own behalf and as representative
of the several Underwriters, hereby consents and agrees to the following):

 

(a)    The
Insider Letter provides in Section 1 thereof for certain requirements of Sponsor and the Insiders in respect of Business Combinations
(as defined therein), including in respect of voting in favor thereof and forgoing redemption rights in respect thereof. The Transactions
constitute a Business Combination and Sponsor and each Insider will comply with its, his or her respective obligations under such
Section 1.

 

(b)    The
Insider Letter provides in Section 3 thereof for certain restrictions on transfer of any Units, Ordinary Shares (including, but
not limited to, Founder Shares), Warrants or any securities convertible into, or exercisable, or exchangeable for, Ordinary Shares
(as such terms are defined therein), during the period ending April 1, 2021. The entry into and performance of the Transaction
Agreement and the agreements delivered in connection therewith or contemplated thereby, including this Agreement, and the conversion
of the Class A Shares and Class B Shares into Class A Common Stock, respectively, in connection with the Domestication, are hereby
permitted by, and shall not constitute a breach or violation of, Section 3 of the Insider Letter.

 

(c)    The
Insider Letter provides in Section 7 thereof for certain restrictions on Transfer of Founder Shares and Class A Ordinary Shares
(as such terms are defined therein) issued upon conversion thereof until the expiration of certain time periods or the happening
of certain prior events. Notwithstanding, and in precedence to, the Insider Letter, from and after the time and date of the Domestication,
(i) references in the Insider Letter to the Class A Shares and Class B Shares (including by reference to Units, Founders Shares
and Warrants, among other things) shall include the shares of Class A Common Stock issued upon conversion of such Class A Shares
and Class B Shares in connection with the Domestication, and (ii) 30% of the number of Class B Shares of Sponsor, as further set
forth under the heading “Earn-Out Shares” on Exhibit A attached hereto opposite such person’s name on
such Exhibit (assuming no stock dividend, subdivision, reclassification, recapitalization, split, combination or exchange of shares,
or any similar event occurs between the date hereof and the Closing), shall no longer be subject to the restrictions on transfer
set forth in the Insider Letter, but shall instead be subject to the provisions set forth in this Section 2(c)
below (such shares, together with the shares of Class A Common Stock issued upon conversion of such shares in connection with the
Domestication, the “Earn-Out Shares”), and the remaining 70% of such Class B Shares (and the shares of Class
A Common Stock issued upon conversion of such shares in connection with the Domestication) and Private Placement Warrants (and
the shares of Class A Common Stock issued upon exercise of such warrants) shall continue to be subject to the restrictions on transfer
set forth in Section 7 of the Insider Letter for the time periods set forth therein. Earn-Out Shares shall continue to be Earn-Out
Shares following their transfer to any permitted transferee under Section 7(c) of the Insider Letter. With respect to Sponsor’s
Earn-Out Shares the Sponsor agrees that it shall not Transfer such Earn-Out Shares until

 

    3 

     

    

(i),
with respect to 50% of such Earn-Out Shares, such time as the Stock Price (as defined below) of the Class A Common Stock equals
or exceeds $12.50 per share for any 20 Trading Days (as defined below) within any 30 Trading Day period after the Closing Date
(as such term is defined in the Transaction Agreement), and (ii) with respect to 50% of such Earn-Out Shares, such time as the
closing price of the Class A Common Stock equals or exceeds $15.00 per share for any 20 Trading Days within any 30 Trading Day
period after the Closing Date. The foregoing restrictions on Transfer in respect of the Earn-Out Shares shall terminate and no
longer be applicable upon the first to occur of (x) the seven-year anniversary of the Closing Date and (y) the date following
the Closing Date on which the Surviving Delaware Corporation completes a liquidation, merger, amalgamation, capital stock exchange,
reorganization or other similar transaction that results in all of the Surviving Delaware Corporation’s Public Shareholders
(as defined in the Insider Letter) having the right to exchange their shares of Class A Common Stock for cash, securities or other
property (a “Liquidation Event”). As used herein, “Stock Price” means, on any date after
the Closing, the closing sale price per share of Class A Common Stock reported as of 4:00 p.m., New York, New York time on such
date by Bloomberg, or if not available on Bloomberg, as reported by Morningstar, and “Trading Day” means any
day on which trading is generally conducted on the New York Stock Exchange or any other exchange on which the shares of Common
Stock are traded and published. For the avoidance of doubt, Sponsor shall be entitled to vote its Earn-Out Shares and receive
dividends and other distributions with respect to such Earn-Out Shares during any period of time that such shares are subject
to restriction on transfer or sale hereunder. If Sponsor transfers Earn-Out Shares in compliance with Section 7(c) of the Insider
Letter, the recipient shall deliver a customary joinder agreement in form and substance reasonably acceptable to VGAC and 23andMe,
and become bound by the transfer restrictions and sale obligations set forth herein.

 

(d)    If,
between the Closing and a Liquidation Event, the outstanding shares of Class A Common Stock shall have been changed into a different
number of shares or a different class, by reason of any stock dividend, subdivision, reclassification, recapitalization, split,
combination or exchange of shares, or any similar transaction affecting the outstanding shares of Class A Common Stock, then any
number, value (including dollar value) or amount contained herein which is based upon the number of shares of Class A Common Stock
will be equitably adjusted for such dividend, subdivision, reclassification, recapitalization, split, combination or exchange of
shares, or any similar transaction. Any adjustment under this Section 2 shall become effective at the date and time that
such stock dividend, subdivision, reclassification, recapitalization, split, combination or exchange of shares, or any similar
transaction became effective. For the avoidance of doubt, the Transactions and the other transactions contemplated by the Transaction
Agreement shall not constitute an event requiring an equitable adjustment hereunder.

 

3.    Working
Capital Loans. The Prospectus (as such term is defined in the Underwriting Agreement) permits loans made by the Sponsor or
an affiliate of the Sponsor or any of the Company’s officers or directors (each, a “Lender”), on such
terms as to be determined by VGAC from time to time, to finance transaction costs in connection with an intended initial Business
Combination (“Working Capital Loans”). Each of the Insider Letter, the Warrant Agreement and the Registration
Rights Agreement contemplates that up to $1,500,000 of Working Capital Loans may be convertible into warrants at a price of $1.50
per warrant, at the option of the Lender. VGAC, Sponsor and each Insider, each on its own behalf and on behalf of its affiliates

 

    4 

     

    

(including
the officers and directors of VGAC), hereby agrees, and shall take such necessary or appropriate actions so as to ensure, that
each and any Working Capital Loan shall be repaid solely in cash, at or prior to the Closing, and that no Working Capital Loan
will be converted into warrants or other securities (derivative or otherwise) of VGAC, notwithstanding any provisions of the Insider
Letter, the Warrant Agreement or any other agreement to the contrary.

 

4.    Registration
Rights Agreement. Each of VGAC, Sponsor, and each Holder hereby agree that the Registration Rights Agreement is being amended
and restated in its entirety, and superseded, in connection with the Closing, and until such time as the Closing occurs (or this
Agreement is terminated in accordance with its terms), all references in the Registration Rights Agreement to the Founder Shares
Lock-Up Period shall mean the period of restriction on Transfer of the Founder Shares set forth in Section 2(c) of this Agreement.

 

5.    Anti-Dilution
Adjustment Waiver. Sponsor, who is the holder of at least a majority of the outstanding Class B Shares, hereby waives on behalf
of the holders of all Class B Shares, pursuant to and in compliance with the provisions of the Amended and Restated Memorandum
and Articles of Association of VGAC (the “Articles”), any adjustment to the conversion ratio set forth in Section
17 of the Articles, and any rights to other anti-dilution protections with respect to the Class B Shares (or the shares of Class
B Common Stock issued upon conversion thereof in connection with the Domestication), that may result from the PIPE Financing (as
such term is defined in the Transaction Agreement) and/or the consummation of the Transactions.

 

6    Acknowledgment.
Each Party understands and acknowledges that each of the other Parties is entering into the Transaction Agreement in reliance upon
such Party’s execution and delivery of this Agreement. Such Party has had the opportunity to read the Transaction Agreement,
this Agreement and the Affected Agreements and has had the opportunity to consult with its tax and legal advisors in respect thereof.

 

7.    Termination.
This Agreement and all of its provisions shall automatically terminate and be of no further force or effect upon the termination
of the Transaction Agreement in accordance with its terms. Upon such termination of this Agreement, all obligations of the Parties
under this Agreement will terminate, without any liability or other obligation on the part of any Party to any person in respect
hereof or the transactions contemplated hereby.

 

8.    Governing
Law. This Agreement, the rights and duties of the Parties, and any disputes (whether in contract, tort or statute) arising
out of, under or in connection with this Agreement will be governed by and construed and enforced in accordance with the Laws of
the State of Delaware, without giving effect to its principles or rules of conflict of laws to the extent such principles or rules
would require or permit the application of the Laws of another jurisdiction. The Parties irrevocably and unconditionally submit
to the exclusive jurisdiction of the United States District Court for the District of Delaware or, if such court does not have
jurisdiction, the Delaware state courts located in Wilmington, Delaware, in any action arising out of or relating to this Agreement.
The Parties irrevocably agree that all such claims shall be heard and determined in such a Delaware federal or state court, and
that such jurisdiction of such courts with respect thereto will be exclusive. Each Party hereby waives, and agrees not to assert,
as a defense in any action, suit or proceeding arising out of or relating to this Agreement that it is not subject to such jurisdiction,
or that such action, suit or proceeding may not be brought or is not maintainable in

 

    5 

     

    

such
courts or that the venue thereof may not be appropriate or that this Agreement may not be enforced in or by such courts. The Parties
hereby consent to and grant any such court jurisdiction over the person of such Parties and over the subject matter of any such
dispute and agree that mailing of process or other papers in connection with any such action, suit or proceeding in the manner
provided in Section 14 or in such other manner as may be permitted by law, will be valid and sufficient service
thereof.

 

9. Waiver
of Jury Trial. To the extent not prohibited by applicable law that cannot be waived, each of the Parties irrevocably waives
any right it may have to trial by jury in respect of any litigation based on, arising out of, under or in connection with this
Agreement or any course of conduct, course of dealing, verbal or written statement or action of any Party or thereto, in each case,
whether now existing or hereafter arising, and whether in contract, tort, statute, equity or otherwise. Each Party hereby further
agrees and consents that any such litigation shall be decided by court trial without a jury and that the Parties to this Agreement
may file a copy of this Agreement with any court as written evidence of the consent of the Parties to the waiver of their right
to trial by jury.

 

10.    Assignment.
This Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the Parties and their respective
heirs, successors and permitted assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder will
be assigned (including by operation of law) without the prior written consent of the Parties.

 

11.    Specific
Performance. The Parties agree that irreparable damage may occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that monetary damages
may not be an adequate remedy for such breach and the non-breaching Party shall be entitled to injunctive relief, in addition to
any other remedy that such Party may have in law or in equity, and to enforce specifically the terms and provisions of this Agreement
in the chancery court or any other state or federal court within the State of Delaware. Without limiting the foregoing, each of
the Parties acknowledges and agrees that 23andMe is a beneficiary of each of the provisions of this Agreement and has the right
to enforce the same it its own name.

 

12.    Amendment.
This Agreement may not be amended, changed, supplemented, waived or otherwise modified or terminated, except upon the execution
and delivery of a written agreement executed by all of the Parties.

 

13.    Severability.
If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions
of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part
or degree will remain in full force and effect to the extent not held invalid or unenforceable.

 

14.    Notices.
All notices, consents, waivers and other communications under this Agreement must be in writing and will be deemed to have been
duly given (a) if personally delivered, on the date of delivery; (b) if delivered by express courier service of national standing
for next day delivery (with charges prepaid), on the Business Day (as such term is defined in the Transaction Agreement) following
the date of delivery to such courier service; (c) if delivered by telecopy (with confirmation of delivery), on the date of transmission
if on a Business Day before

 

    6 

     

    

5:00
p.m. local time of the recipient Party (otherwise on the next succeeding Business Day); (d) if delivered by electronic mail, on
the date of transmission if on a Business Day before 5:00 p.m. local time of the business address of the recipient Party (otherwise
on the next succeeding Business Day); and (e) if deposited in the United States mail, first-class postage prepaid, on the date
of delivery, in each case to the appropriate addresses or electronic mail addresses set forth below (or to such other addresses
or electronic mail addresses as a Party may designate by notice to the other Parties in accordance with this Section 14):

 

		(a)	If to VGAC, to its address of record under the Transaction Agreement;

 

		(b)	If to Credit Suisse as representative of the several Underwriters, to its address of record under
the Underwriting Agreement;

 

		(c)	If to the Sponsor or to the Insiders, to their respective addresses of record under the Insider
Letter; and

 

		(d)	If to the Holders, to their respective addresses of record under the Registration Rights Agreement.

 

15.    Counterparts.
This Agreement may be executed in two or more counterparts (any of which may be delivered by facsimile or electronic transmission),
each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument.

 

16.    Entire
Agreement. In the event and to the extent that there shall be a conflict between the provisions of this Agreement and the provisions
of any Affected Agreement, this Agreement shall control with respect to the subject matter thereof. This Agreement and the Transaction
Agreement constitute the entire agreement and understanding of the Parties in respect of the subject matter hereof and supersedes
all prior understandings, agreements or representations by or among the Parties to the extent they relate in any way to the subject
matter hereof.

 

[Signature Page Follows]

 

    7 

     

    

IN WITNESS WHEREOF,
the Parties have each caused this VGAC Letter Agreement to be duly executed as of the date first written above.

 

 

	VGAC:	 	VG ACQUISITION CORP.
	 	 	 
	 	 	By:  	/s/ Evan Lovell
	  	 	Name:	Evan Lovell
	 	 	Title:    	Chief Financial Officer
	 	 	 	 
	CREDIT SUISSE:	 	CREDIT SUISSE SECURITIES (USA) LLC
	 	 	 
	 	 	By:  	/s/ John Hoffman
	 	 	Name:  	 John Hoffman
	 	 	Title:    	Managing Director, ECM
	 	 	 	 
	 	 	Acting on behalf of itself and as the representative of the several Underwriters
	 	 	 
	SPONSOR:	 	VG ACQUISITION SPONSOR LLC
	 	 	 
	 	 	By:  Corvina Holdings Limited, 
	 	 	its manager
	 	 	 
	 	 	By:  	/s/ Clifton Struiken
	 	 	Name:  	Clifton Struiken
	 	 	Title:    	Alternate Director
	 	 	 	 
	INSIDERS:	 	 	/s/ Douglas R. Brown
	 	 	 	Douglas R. Brown, individually
	 	 	 	 
	 	 	 	/s/ Teresa Briggs
	 	 	 	Teresa Briggs, individually
	 	 	 	 
	 	 	 	/s/ James B. Lockhart III
	 	 	 	James B. Lockhart III, individually
	 	 	 	 
	 	 	 	/s/ Evan Lovell
	 	 	 	Evan Lovell, individually
	 	 	 	 
	 	 	 	/s/ Josh Bayliss
	 	 	 	Josh Bayliss, individually

 

[ Signature Page to VGAC Letter Agreement
(continues on following page) ]

 

    8 

     

    

IN WITNESS WHEREOF,
the Parties have each caused this VGAC Letter Agreement to be duly executed as of the date first written above.

 

	 	 	23ANDME, INC.	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 	 
	 	 	By:  	 /s/ Anne Wojcicki	 
	 	 	Name:  	 Anne Wojcicki	 
	 	 	Title:    	Chief Executive Officer	 

 

 

 

 

 

 

 

 

 

 

[ Signature Page to VGAC Letter Agreement
(continued) ]

 

 

    9Exhibit 10.2

 

 

Execution
Version

 

SUBSCRIPTION
AGREEMENT

 

This SUBSCRIPTION
AGREEMENT (this “Subscription Agreement”) is entered into this 4th  day of February 2021, by and between VG
Acquisition Corp., a Cayman Islands exempted company (the “Issuer”), and the undersigned (“Subscriber”
or “you”). Defined terms used but not otherwise defined herein shall have the respective meanings ascribed
thereto in the Business Combination Agreement (as defined below).

 

WHEREAS,
the Issuer, 23andMe, Inc., a Delaware corporation (“23andMe”), and the other parties named therein will, immediately
following the execution of this Subscription Agreement, enter into that certain Agreement and Plan of Merger, dated as of the
date hereof (as amended, modified, supplemented or waived from time to time in accordance with its terms, the “Business
Combination Agreement”), pursuant to which a wholly owned subsidiary of the Issuer will merge with and into 23andMe,
with 23andMe surviving as a wholly owned subsidiary of the Issuer (together with the other transactions contemplated by the Business
Combination Agreement, the “Transactions”);

 

WHEREAS,
in connection with the Transactions, Subscriber desires to subscribe for and purchase from the Issuer, immediately following the
conversion of the Issuer to a Delaware corporation, that number of shares of the Issuer’s common stock (the “Common
Shares”) set forth on the signature page hereto (the “Subscribed Shares”) for a purchase price of
$10.00 per share, and for the aggregate purchase price set forth on the signature page hereto (the “Purchase Price”),
and the Issuer desires to issue and sell to Subscriber the Subscribed Shares in consideration of the payment of the Purchase Price
therefor by or on behalf of Subscriber to the Issuer, all on the terms and subject to the conditions set forth herein; and

 

WHEREAS,
certain other “qualified institutional buyers” (as defined in Rule 144A under the Securities Act of 1933, as amended
(the “Securities Act”)) or “accredited investors” (within the meaning of Rule 501(a) under the
Securities Act) (each, an “Other Subscriber”) have, severally and not jointly, entered into separate subscription
agreements with the Issuer that are substantially similar to this Subscription Agreement (the “Other Subscription Agreements”),
pursuant to which such Other Subscribers have agreed to purchase Common Shares on the Closing Date (as defined below) at the same
per share purchase price as Subscriber, and the aggregate amount of securities to be sold by the Issuer pursuant to this Subscription
Agreement and the Other Subscription Agreements equals, as of the date hereof, 25,000,000 Common Shares.

 

NOW, THEREFORE,
in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, herein
contained, and intending to be legally bound hereby, the parties hereto hereby agree as follows:

 

For ease
of administration, this single Subscription Agreement is being executed so as to enable each Subscriber identified on the signature
page to enter into a Subscription Agreement, severally, but not jointly. The parties agree that (i) this Subscription Agreement
shall be treated as if it were a separate agreement with respect to each Subscriber listed on the signature page, as if each Subscriber
entity had executed a separate Subscription Agreement naming only itself as Subscriber, and (ii) no Subscriber listed on the signature
page shall have any liability under the

 

     

     

    

Subscription
Agreement for the obligations of any Other Subscriber so listed. The decision of Subscriber to purchase the Subscribed Shares
pursuant to this Subscription Agreement has been made by Subscriber independently of any Other Subscriber or any other investor
and independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties,
liabilities, results of operations, condition (financial or otherwise) or prospects of the Issuer, 23andMe or any of their respective
subsidiaries which may have been made or given by any Other Subscriber or investor or by any agent or employee of any Other Subscriber
or investor, and neither Subscriber nor any of its agents or employees shall have any liability to any Other Subscriber or investor
(or any other person) relating to or arising from any such information, materials, statements or opinions. Nothing contained herein
or in any Other Subscription Agreement, and no action taken by Subscriber or investor pursuant hereto or thereto, shall be deemed
to constitute Subscriber and Other Subscribers or other investors as a partnership, an association, a joint venture or any other
kind of entity, or create a presumption that Subscriber and Other Subscribers or other investors are in any way acting in concert
or as a group with respect to such obligations or the transactions contemplated by this Subscription Agreement and the Other Subscription
Agreements. Subscriber acknowledges that no Other Subscriber has acted as agent for Subscriber in connection with making its investment
hereunder and no Other Subscriber will be acting as agent of Subscriber in connection with monitoring its investment in the Subscribed
Shares or enforcing its rights under this Subscription Agreement. Subscriber shall be entitled to independently protect and enforce
its rights, including without limitation the rights arising out of this Subscription Agreement, and it shall not be necessary
for any Other Subscriber or investor to be joined as an additional party in any proceeding for such purpose.

 

1.       Subscription.
Subject to the terms and conditions hereof, at the Closing (as defined below), Subscriber hereby agrees, upon the substantially
concurrent consummation of the Transactions, to subscribe for and purchase, and the Issuer hereby agrees to issue and sell to
Subscriber, upon the payment of the Purchase Price, the Subscribed Shares (such subscription and issuance, the “Subscription”).
Notwithstanding anything herein to the contrary, the consummation of the Subscription is contingent upon the subsequent occurrence
of the closing of the Transactions as further described herein. Each of the parties hereto acknowledge and agree that the Subscribed
Shares that will be issued pursuant hereto shall be shares of common stock in a Delaware corporation (and not shares in a Cayman
Islands exempted company).

 

2.       Representations,
Warranties and Agreements.

 

2.1.       Subscriber’s
Representations, Warranties and Agreements. To induce the Issuer to issue the Subscribed Shares, Subscriber hereby represents
and warrants to the Issuer and acknowledges and agrees with the Issuer, as of the date hereof and as of the Closing Date, as follows:

 

2.1.1.       If
Subscriber is not an individual, Subscriber has been duly formed or incorporated and is validly existing in good standing under
the laws of its jurisdiction of incorporation or formation, with power and authority to enter into, deliver and perform its obligations
under this Subscription Agreement. If Subscriber is an

 

    2 

     

    

individual,
Subscriber has the authority to enter into, deliver and perform its obligations under this Subscription Agreement.

 

2.1.2.       If
Subscriber is not an individual, this Subscription Agreement has been duly authorized, validly executed and delivered by Subscriber.
If Subscriber is an individual, the signature on this Subscription Agreement is genuine, and Subscriber has legal competence and
capacity to execute the same. Assuming that this Subscription Agreement constitutes the valid and binding agreement of the Issuer,
this Subscription Agreement is the valid and binding obligation of Subscriber, and is enforceable against Subscriber in accordance
with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered
at law or equity.

 

2.1.3.       The
execution, delivery and performance by Subscriber of this Subscription Agreement and the consummation of the transactions contemplated
herein do not and will not (i) if Subscriber is not an individual, result in any violation of the provisions of the organizational
documents of Subscriber or any of its subsidiaries or (ii) result in any violation of any statute or any judgment, order, rule
or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over Subscriber that would
reasonably be expected to have a material adverse effect on the legal authority of Subscriber to enter into and timely perform
its obligations under this Subscription Agreement (a “Subscriber Material Adverse Effect”).

 

2.1.4.       Subscriber
(i) is (a) a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an “accredited
investor” within the meaning of Rule 501(a) under the Securities Act, (b) an Institutional Account as defined in FINRA Rule
4512(c) and (c) a sophisticated institutional investor, experienced in investing in transactions of the type contemplated by this
Subscription Agreement and capable of evaluating investment risks independently, both in general and with regard to all transactions
and investment strategies involving a security or securities, including Subscriber’s participation in the purchase of the
Subscribed Shares, in each case, satisfying the applicable requirements set forth on Schedule I, (ii) is acquiring the
Subscribed Shares only for its own account and not for the account of others, or if Subscriber is subscribing for the Subscribed
Shares as a fiduciary or agent for one or more investor accounts, each owner of such account is a qualified institutional buyer,
and Subscriber has full investment discretion with respect to each such account, and the full power and authority to make the
acknowledgements, representations, warranties and agreements herein on behalf of each owner of each such account, for investment
purposes only and not with a view to any distribution of the Subscribed Shares in any manner that would violate the securities
laws of the United States or any other applicable jurisdiction and (iii) is not acquiring the Subscribed Shares with a view to,
or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested
information on Schedule I following the signature page hereto). Subscriber is not an entity formed for the specific purpose
of acquiring the Subscribed Shares.

 

    3 

     

    

2.1.5.       Subscriber
understands that the Subscribed Shares are being offered in a transaction not involving any public offering within the meaning
of the Securities Act and that the Subscribed Shares have not been registered under the Securities Act. Except in respect of any
stock lending program, Subscriber understands that the Subscribed Shares may not be resold, transferred, pledged or otherwise
disposed of by Subscriber absent an effective registration statement under the Securities Act, except (i) to the Issuer or a subsidiary
thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur solely outside the United States within the meaning
of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements
of the Securities Act, and in each of cases ‎(i) and ‎(iii), in accordance with any applicable securities
laws of the states and other jurisdictions of the United States, and that the Subscribed Shares shall be subject to a legend to
such effect (provided that such legends will be eligible for removal upon compliance with the relevant resale provisions of Rule
144). Subscriber acknowledges that the Subscribed Shares will not be eligible for resale pursuant to Rule 144A promulgated under
the Securities Act. Subscriber understands and agrees that the Subscribed Shares will be subject to the foregoing restrictions
and, as a result, Subscriber may not be able to readily resell the Subscribed Shares and may be required to bear the financial
risk of an investment in the Subscribed Shares for an indefinite period of time. Subscriber understands that it has been advised
to consult independent legal counsel prior to making any offer, resale, pledge or transfer of any of the Subscribed Shares. Subscriber
has determined based on its own independent review and such professional advice as it deems appropriate that the Subscribed Shares
are a suitable investment for Subscriber, notwithstanding the substantial risks inherent in investing in or holding the Subscribed
Shares.

 

2.1.6.       Subscriber
understands and agrees that Subscriber is purchasing the Subscribed Shares directly from the Issuer. Subscriber further acknowledges
that there have been no representations, warranties, covenants or agreements made to Subscriber by the Issuer, 23andMe, or any
of their respective officers or directors, expressly or by implication, other than those representations, warranties, covenants
and agreements expressly set forth in this Subscription Agreement.

 

2.1.7.       If
Subscriber is an employee benefit plan that is subject to Title I of the Employee Retirement Income Security Act of 1974, as amended
(“ERISA”), Subscriber represents and warrants that its acquisition and holding of the Subscribed Shares will
not constitute or result in a non-exempt prohibited transaction under Section 406 of ERISA, Section 4975 of the Internal Revenue
Code of 1986, as amended (the “Code”), or any applicable other federal, state, local, non-U.S. or other laws
or regulations that are similar to such provisions of ERISA or the Code (collectively, “Similar Laws”).

 

2.1.8.       In
making its decision to purchase the Subscribed Shares, Subscriber represents that it has relied solely upon independent investigation
made by Subscriber and the representations, warranties and covenants of the Issuer contained in this Subscription Agreement. Without
limiting the generality of the foregoing, Subscriber

 

    4 

     

    

has
not relied on any statements or other information provided by anyone (including Credit Suisse Securities (USA) LLC and Citigroup
Global Markets Inc. (collectively, in their capacity as placement agents, the “Placement Agents”)), other than
the Issuer and its representatives concerning the Issuer or the Subscribed Shares or the offer and sale of the Subscribed Shares.
Subscriber acknowledges and agrees that Subscriber has received access to and has had an adequate opportunity to review such information
as Subscriber deems necessary in order to make an investment decision with respect to the Subscribed Shares, including with respect
to the Issuer, 23andMe and the Transactions. Subscriber represents and agrees that Subscriber and Subscriber’s professional
advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as Subscriber
and such Subscriber’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect
to the Subscribed Shares. Subscriber represents and warrants it is relying exclusively on its own sources of information, investment
analysis and due diligence (including professional advice you deem appropriate) with respect to the Transactions, the Subscribed
Shares and the business, condition (financial and otherwise), management, operations, properties and prospects of the Issuer and
23andMe including but not limited to all business, legal, regulatory, accounting, credit and tax matters. Subscriber further acknowledges
that Subscriber has not relied upon the Placement Agents in connection with Subscriber’s due diligence review of the offering
of the Subscribed Shares and the Issuer.

 

2.1.9.       Subscriber
acknowledges and agrees that (a) it has been informed that each of the Placement Agents is acting solely as placement agent in
connection with the Transactions and is not acting as an underwriter or in any other capacity in connection with the Subscriptions
and is not and shall not be construed as a fiduciary for Subscriber in connection with the Transactions, (b) the Placement Agents
have not made and will not make any representation or warranty, whether express or implied, of any kind or character and have
not provided any advice or recommendation in connection with the Transactions, in each case, to Subscriber (c) the Placement Agents
will have no responsibility to Subscriber with respect to (i) any representations, warranties or agreements made by any person
or entity under or in connection with the Transactions or any of the documents furnished pursuant thereto or in connection therewith,
or the execution, legality, validity or enforceability (with respect to any person) or any thereof, or (ii) the business, condition
(financial and otherwise), management, operations, properties or prospects of, the Issuer, 23andMe or the Transactions, and (d)
the Placement Agents shall have no liability or obligation (including without limitation, for or with respect to any losses, claims,
damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements incurred by Subscriber), whether
in contract, tort or otherwise, to Subscriber, or to any person claiming through Subscriber, in respect of the Transactions. Subscriber
further acknowledges that Citigroup Global Markets Inc. is acting as financial advisor to 23andMe in connection with the Transactions.
Issuer and 23andMe are solely responsible for paying any fees or other commission owed to the Placement Agents in connection with
the Transactions.

 

2.1.10.       Subscriber
became aware of this offering of the Subscribed Shares solely by means of direct contact between Subscriber and the Issuer or
one of their

 

    5 

     

    

respective
representatives. Subscriber did not become aware of this offering of the Subscribed Shares, nor were the Subscribed Shares offered
to Subscriber, by any general solicitation. Subscriber acknowledges that the Issuer represents and warrants that the Subscribed
Shares were not offered by any form of general solicitation or general advertising, including methods described in section 502(c)
of Regulation D under the Securities Act.

 

2.1.11.       Subscriber
understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Subscribed
Shares or made any findings or determination as to the fairness of an investment in the Subscribed Shares.

 

2.1.12.       Subscriber
represents and warrants that Subscriber is not (i) a person or entity named on the List of Specially Designated Nationals and
Blocked Persons administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”)
or in any Executive Order issued by the President of the United States and administered by OFAC (“OFAC List”),
or a person or entity prohibited by any OFAC sanctions program, (ii) a Designated National as defined in the Cuban Assets Control
Regulations, 31 C.F.R. Part 515 or (iii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank.
Subscriber agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable law, provided
that Subscriber is permitted to do so under applicable law. If Subscriber is a financial institution subject to the Bank Secrecy
Act (31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001, and its implementing regulations (collectively,
the “BSA/PATRIOT Act”), Subscriber represents that it maintains policies and procedures reasonably designed
to comply with applicable obligations under the BSA/PATRIOT Act. Subscriber also represents that, to the extent required, it maintains
policies and procedures reasonably designed for the screening of its investors against the OFAC sanctions programs, including
the OFAC List. Subscriber further represents and warrants that, to the extent required, it maintains policies and procedures reasonably
designed to ensure that the funds held by Subscriber and used to purchase the Subscribed Shares were legally derived.

 

2.1.13.       If
Subscriber is an employee benefit plan that is subject to Title I of ERISA, a plan, an individual retirement account or other
arrangement that is subject to section 4975 of the Code or an employee benefit plan that is a governmental plan (as defined in
section 3(32) of ERISA), a church plan (as defined in section 3(33) of ERISA), a non-U.S. plan (as described in section 4(b)(4)
of ERISA) or other plan that is not subject to the foregoing but may be subject to provisions under any other Similar Laws or
an entity whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement
(each, a “Plan”), Subscriber represents and warrants that neither the Issuer nor any of its affiliates (the
“Transaction Parties”) has acted as the Plan’s fiduciary, or has been relied on for advice, with respect
to its decision to acquire and hold the Subscribed Shares, and none of the Transaction Parties shall at any time be relied upon
as the Plan’s fiduciary with respect to any decision to acquire, continue to hold or transfer the Subscribed Shares.

 

    6 

     

    

2.1.14.       Except
as expressly disclosed in a Schedule 13D or Schedule 13G (or amendments thereto) filed by such Subscriber with the United States
Securities and Exchange Commission (the “Commission”) with respect to the beneficial ownership of the Issuer’s
securities, Subscriber is not currently (and at all times through Closing will refrain from being or becoming) a member of a “group”
(within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or any successor provision) acting for the purpose of acquiring, holding or disposing of equity securities of
the Issuer (within the meaning of Rule 13d-5(b)(1) under the Exchange Act).

 

2.1.15.       Subscriber
is not a foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign
state have a substantial interest (as defined in 31 C.F.R. Part 800.244) and that will acquire a substantial interest in the Issuer
as a result of the purchase and sale of Subscribed Shares hereunder such that a declaration to the Committee on Foreign Investment
in the United States would be mandatory under 31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31
C.F.R. Part 800.208) over the Issuer from and after the Closing as a result of the purchase and sale of the Subscribed Shares
hereunder.

 

2.1.16.       On
each date the Purchase Price would be required to be funded to the Issuer pursuant to Section ‎3.1 Subscriber
will have, sufficient immediately available funds to pay the Purchase Price pursuant to Section ‎3.1.

 

2.1.17.       No
broker, finder or other financial consultant has acted on behalf of Subscriber in connection with this Subscription Agreement
or the transactions contemplated hereby in such a way as to create any liability on the Issuer.

 

2.1.18.       Subscriber
agrees that, from the date of this Subscription Agreement until the Closing or the earlier termination of this Subscription Agreement,
none of Subscriber, its controlled affiliates, or any person or entity acting on behalf of Subscriber or any of its controlled
affiliates or pursuant to any understanding with Subscriber or any of its controlled affiliates will engage in any Short Sales
with respect to securities of the Issuer. For the purposes hereof, “Short Sales” shall include, without limitation,
all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of
direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage arrangements),
forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), including through
non-U.S. broker dealers or foreign regulated brokers.

 

2.2.       Issuer’s
Representations, Warranties and Agreements. To induce Subscriber to purchase the Subscribed Shares, the Issuer hereby represents
and warrants to Subscriber and agrees with Subscriber, as of the date hereof and as of the Closing Date, as follows:

 

    7 

     

    

2.2.1.       The
Issuer has been duly incorporated and is validly existing and in good standing under the laws of its jurisdiction of incorporation
or formation, with all requisite power and authority to own, lease and operate its properties and conduct its business as presently
conducted and to enter into, deliver and perform its obligations under this Subscription Agreement. As of the Closing Date, the
Issuer will be duly incorporated, validly existing and in good standing under the laws of the State of Delaware.

 

2.2.2.       The
Subscribed Shares will be duly authorized and, when issued and delivered to Subscriber against full payment for the Subscribed
Shares, will be free and clear of any liens or other restrictions whatsoever in accordance with the terms of this Subscription
Agreement and registered with the Issuer’s transfer agent, the Subscribed Shares will be validly issued, fully paid and
non-assessable and will not have been issued in violation of or subject to any preemptive or similar rights under the Issuer’s
constitutive agreements or applicable law.

 

2.2.3.       This
Subscription Agreement has been duly authorized, validly executed and delivered by the Issuer and, assuming that this Subscription
Agreement constitutes the valid and binding obligation of the Subscriber, is the valid and binding obligation of the Issuer, and
is enforceable against Issuer in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally
and (ii) principles of equity, whether considered at law or equity.

 

2.2.4.       The
execution, delivery and performance of this Subscription Agreement (including compliance by the Issuer with all of the provisions
hereof), the issuance and sale of the Subscribed Shares and the consummation of the other transactions contemplated herein, including
the Transactions, will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute
a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets
of the Issuer or any of its subsidiaries pursuant to the terms of any indenture, mortgage, charge, deed of trust, loan agreement,
lease, license or other agreement or instrument to which the Issuer or any of its subsidiaries is a party or by which the Issuer
or any of its subsidiaries is bound or to which any of the property or assets of the Issuer or any of its subsidiaries is subject,
which would reasonably be expected to have a material adverse effect on the business, properties, financial condition, stockholders’
equity or results of operations of the Issuer or 23andMe or their respective subsidiaries individually or taken as a whole and
including the combined company after giving effect to the Transactions, or materially affects the validity or enforceability of
the Subscribed Shares or the legal authority or other ability of the Issuer to enter into and timely perform its obligations under
this Subscription Agreement (collectively, an “Issuer Material Adverse Effect”), (ii) result in any violation
of the provisions of the organizational documents of the Issuer or any of its subsidiaries or (iii) result in any violation of
any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having
jurisdiction over the Issuer or

 

    8 

     

    

any
of its subsidiaries or any of its properties that would reasonably be expected to have an Issuer Material Adverse Effect.

 

2.2.5.       Neither
the Issuer, nor any person acting on its behalf has, directly or indirectly, made any offers or sales of any security of the Issuer
nor solicited any offers to buy any security under circumstances that would adversely affect reliance by the Issuer on Section
4(a)(2) of the Securities Act for the exemption from registration for the transactions contemplated hereby or would require registration
of the issuance of the Subscribed Shares under the Securities Act.

 

2.2.6.       Neither
the Issuer, nor any person acting on its behalf has conducted any general solicitation or general advertising, including methods
described in section 502(c) of Regulation D under the Securities Act, in connection with the offer or sale of any of the Subscribed
Shares and neither the Issuer, nor any person acting on its behalf has offered any of the Subscribed Shares in a manner involving
a public offering under, or in a distribution in violation of, the Securities Act or any state securities laws.

 

2.2.7.       Concurrently
with the execution and delivery of this Subscription Agreement, the Issuer is entering into the Other Subscription Agreements
providing for the sale of an aggregate of 25,000,000 Common Shares for an aggregate purchase price of $250,000,000 (including
the Subscribed Shares purchased and sold under this Subscription Agreement ). There are no Other Subscription Agreements, side
letter agreements or other agreements or understandings (including written summaries of any oral understandings) with any Other
Subscriber or any other investor or potential investor with respect to the purchase of equity securities of the Issuer (other
than as described in the last sentence of this Section 2.2.7 and pursuant to the Business Combination Agreement) which include
terms and conditions (economic or otherwise) that are materially more advantageous to any such Other Subscriber, investor or potential
investor (as compared to Subscriber). The Other Subscription Agreements have not been amended or modified in any material respect
following the date of this Subscription Agreement. This Section 2.2.7 shall not apply to any purchase of any equity securities
of the Issuer by the Anne Wojcicki Foundation, by the sponsor of VG Acquisition Corp., or any of their respective affiliates.

 

2.2.8.       As
of the date of this Subscription Agreement and as of immediately prior to the Transactions, the authorized share capital of the
Issuer consists of 200,000,000 Class A ordinary shares, 20,000,000 Class B ordinary shares and 1,000,000 preference shares, $0.0001
par value each. All issued and outstanding ordinary shares of the Issuer have been duly authorized and validly issued, are fully
paid, non-assessable and are not subject to preemptive or similar rights. Except as set forth above and pursuant to the Other
Subscription Agreements and the Business Combination Agreement, there are no outstanding, and between the date hereof and the
Closing, the Issuer will not issue, sell or cause to be outstanding any (a) shares, equity interests or voting securities of the
Issuer, (b) securities of the Issuer convertible into or exchangeable for shares or other equity interests or voting securities
of the Issuer, (c) options, warrants or other rights (including preemptive rights) or agreements, arrangements or

 

    9 

     

    

commitments
of any character, whether or not contingent, of the Issuer to subscribe for, purchase or acquire from any individual, entity or
other person, and no obligation of the Issuer to issue, any ordinary shares of the Issuer, or any other equity interests or voting
securities in the Issuer or any securities convertible into or exchangeable or exercisable for such shares or other equity interests
or voting securities, (d) equity equivalents or other similar rights of or with respect to the Issuer, or (e) obligations of the
Issuer to repurchase, redeem, or otherwise acquire any of the foregoing securities, shares, options, equity equivalents, interests
or rights. There are no shareholder agreements, voting trusts or other agreements or understandings to which the Issuer is a party
or by which it is bound relating to the voting of any securities of the Issuer, other than as contemplated by the Business Combination
Agreement and the Transaction Agreements (as defined in the Business Combination Agreement). There are no securities or instruments
issued by or to which the Issuer is a party containing anti-dilution or similar provisions that will be triggered by the issuance
of (i) the Subscribed Shares or (ii) the shares to be issued pursuant to any Other Subscription Agreement that have not been or
will not be validly waived on or prior to the closing of the Transactions.

 

2.2.9.       Assuming
the accuracy of Subscriber’s representations and warranties set forth in Section ‎2.1 of this Subscription
Agreement, (i) no registration under the Securities Act is required for the offer and sale of the Subscribed Shares by the Issuer
to Subscriber and (ii) no consent, approval, order or authorization of, or registration, qualification, designation, declaration
or filing with, any federal, state or local governmental authority is required on the part of the Issuer in connection with the
consummation of the transactions contemplated by this Subscription Agreement, except for filings pursuant to Regulation D of the
Securities Act and applicable state securities laws and filings required to consummate the Transactions as provided under the
Business Combination Agreement.

 

2.2.10.       There
are no pending or, to the knowledge of the Issuer, threatened, suits, claims, actions, or proceedings, which, if determined adversely,
would, individually or in the aggregate, reasonably be expected to have an Issuer Material Adverse Effect. There is no unsatisfied
judgment or any open injunction binding upon the Issuer, which would, individually or in the aggregate, reasonably be expected
to have an Issuer Material Adverse Effect.

 

2.2.11.       The
Issuer is in compliance with all applicable laws, except where such non-compliance would not reasonably be expected to be material.
The Issuer has not received any written communication from a governmental entity, exchange or self regulatory organization that
alleges that the Issuer is not in compliance with or is in default or violation of any applicable law, except where such non-compliance,
default or violation would not, individually or in the aggregate, be reasonably expected to be material.

 

2.2.12.       The
Issuer is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority, self-regulatory

 

    10 

     

    

organization
or other person in connection with the execution, delivery and performance by the Issuer of this Subscription Agreement (including,
without limitation, the issuance of the Subscribed Shares), other than (i) filings with the Commission, (ii) filings required
by applicable state securities laws, (iii) filings required in accordance with Section ‎‎4, (iv) those required
by the New York Stock Exchange (the “NYSE”) or Nasdaq, and (v) filings, the failure of which to obtain would
not be reasonably be expected to have, individually or in the aggregate, an Issuer Material Adverse Effect.

 

2.2.13.       At
Closing, the Issuer will be classified as a domestic corporation for U.S. federal income tax purposes.

 

2.2.14.       The
Issuer made available to Subscriber (including via the Commission’s EDGAR system) a true, correct and complete copy of each
form, report, statement, schedule, prospectus, proxy, registration statement and other documents filed by the Issuer with the
Commission prior to the date of this Subscription Agreement (the “SEC Documents”), which SEC Documents, as
of their respective filing dates, complied in all material respects with the requirements of the Exchange Act applicable to the
SEC Documents and the rules and regulations of the Commission promulgated thereunder and applicable to the SEC Documents. As of
their respective dates, all SEC Documents required to be filed by the Issuer with the Commission prior to the date hereof complied
in all material respects with the applicable requirements of the Securities Act and the Exchange Act and the rules and regulations
of the Commission promulgated thereunder. None of the SEC Documents filed under the Exchange Act, contained, when filed or, if
amended prior to the date of this Subscription Agreement, as of the date of such amendment with respect to those disclosures that
are amended, any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading; provided that the Issuer
makes no such representation or warranty with respect to the registration statement on Form S-4 to be filed by the Issuer with
respect to the Transactions or any other information relating to 23andMe or any of its affiliates included in any SEC Document
or filed as an exhibit thereto. The Issuer has timely filed each report, statement, schedule, prospectus, and registration statement
that the Issuer was required to file with the Commission since its inception and through the date hereof. There are no material
outstanding or unresolved comments in comment letters from the Commission staff with respect to any of the SEC Documents.

 

2.2.15.       No
broker, finder or other financial consultant has acted on behalf of the Issuer in connection with this Subscription Agreement
or the transactions contemplated hereby in such a way as to create any liability on Subscriber.

 

2.2.16.       The
Issuer is not, and immediately after receipt of payment for the Subscribed Shares will not be, an “investment company”
within the meaning of the Investment Company Act of 1940, as amended.

 

    11 

     

    

3.       Settlement
Date and Delivery.

 

3.1.       Closing.
The closing of the Subscription contemplated hereby (the “Closing”) shall occur on the date of, and immediately
prior to (but subject to), the consummation of the Transactions (the date of the Closing, the “Closing Date”).
Upon written notice from (or on behalf of) the Issuer to Subscriber (the “Closing Notice”) at least five (5)
Business Days prior to the date that the Issuer reasonably expects all conditions to the closing of the Transactions to be satisfied
(the “Expected Closing Date”), upon satisfaction (or, if applicable, waiver) of the conditions set forth in
this Section 3, Subscriber shall deliver to the Issuer, the Purchase Price for the Subscribed Shares, (i) no later than two (2)
Business Days prior to the Expected Closing Date by wire transfer of United States dollars in immediately available funds to the
account specified by the Issuer in the Closing Notice, such funds to be held by the Issuer in escrow until the Closing, or (ii)
to an account specified by the Issuer and as otherwise mutually agreed by the Subscriber and the Issuer (“Alternative
Settlement Procedures”). For the avoidance of doubt, mutually agreeable Alternative Settlement Procedures shall include,
without limitation, the Subscriber delivering to the Issuer on the Closing Date the Purchase Price for the Subscribed Shares by
wire transfer of U.S. dollars in immediately available funds to the account specified by the Issuer in the Closing Notice against
delivery to the undersigned of the Subscribed Shares. On the Closing Date, the Issuer shall issue to Subscriber (or the funds
and accounts designated by Subscriber if so designated by Subscriber, or its nominee in accordance with its delivery instructions)
or to a custodian designated by Subscriber, as applicable, the Subscribed Shares, free and clear of any liens or other restrictions
whatsoever (other than those arising under state or federal securities laws), which Subscribed Shares, unless otherwise determined
by the Issuer, shall be uncertificated, with record ownership reflected only in the register of shareholders of the Issuer and
shall, prior to Subscriber delivering the funds on the Closing Date as provided in clause (i), provide evidence of such issuance
from the Issuer’s transfer agent showing Subscriber as the owner of the Subscribed Shares on and as of the Closing Date.
If the Transactions are not consummated within one (1) Business Day after the Expected Closing Date, the Issuer shall promptly
(but no later than one (1) Business Day thereafter) return the Purchase Price to Subscriber by wire transfer of United States
dollars in immediately available funds to an account specified by Subscriber, and the Subscribed Shares shall be cancelled. Notwithstanding
such return, (i) a failure to close on the Expected Closing Date shall not, by itself, be deemed to be a failure of any of the
conditions to Closing set forth in this Section 3 to be satisfied or waived on or prior to the Closing Date, and (ii) unless and
until this Subscription Agreement is terminated in accordance with Section 5 hereof, Subscriber shall remain obligated (A) to
redeliver funds to the Issuer following the Issuer’s delivery to Subscriber of a new Closing Notice and (B) to consummate
the Closing upon satisfaction of the conditions set forth in this Section 3. For purposes of this Subscription Agreement,
“Business Day” means any day that, in New York, New York, is neither a legal holiday nor a day on which banking
institutions are generally authorized or required by law or regulation to close.

 

3.2.       Conditions
to Closing of the Issuer.

 

The Issuer’s
obligations to sell and issue the Subscribed Shares at the Closing are subject to the fulfillment or (to the extent permitted
by applicable law) written waiver by the Issuer, on or prior to the Closing Date, of each of the following conditions:

 

    12 

     

    

3.2.1.       Representations
and Warranties Correct. The representations and warranties made by Subscriber in Section ‎2.1 hereof shall
be true and correct in all material respects when made (other than representations and warranties that are qualified as to materiality
or Subscriber Material Adverse Effect, which representations and warranties shall be true and correct in all respects), and shall
be true and correct in all material respects on and as of the Closing Date (unless they specifically speak as of another date
in which case they shall be true and correct in all material respects as of such date) (other than representations and warranties
that are qualified as to materiality or Subscriber Material Adverse Effect, which representations and warranties shall be true
in all respects) with the same force and effect as if they had been made on and as of said date, but in each case without giving
effect to consummation of the Transactions.

 

3.2.2.       Compliance
with Covenants. Subscriber shall have performed, satisfied and complied in all material respects with the covenants, agreements
and conditions required by this Subscription Agreement to be performed, satisfied or complied with by Subscriber at or prior to
the Closing.

 

3.2.3.       Closing
of the Transactions. All conditions precedent to each of the Issuer’s and 23andMe’s obligations to consummate,
or cause to be consummated, the Transactions set forth in the Business Combination Agreement shall have been satisfied or waived
by the party entitled to the benefit thereof under the Business Combination Agreement (other than those conditions that may only
be satisfied at the consummation of the Transactions, but subject to satisfaction or waiver by such party of such conditions as
of the consummation of the Transactions), and the Transactions will be consummated immediately following the Closing.

 

3.2.4.       Legality.
There shall not be in force any order, judgment, injunction, decree, writ, stipulation, determination or award, in each case,
entered by or with any governmental authority, statute, rule or regulation enjoining or prohibiting the consummation of the Subscription.

 

3.3.       Conditions
to Closing of Subscriber.

 

Subscriber’s
obligation to purchase the Subscribed Shares at the Closing is subject to the fulfillment or (to the extent permitted by applicable
law) written waiver by Subscriber, on or prior to the Closing Date, of each of the following conditions:

 

3.3.1.       Representations
and Warranties Correct. The representations and warranties made by the Issuer in Section ‎2.2 hereof shall
be true and correct in all material respects when made (other than representations and warranties that are qualified as to materiality
or Issuer Material Adverse Effect, which representations and warranties shall be true and correct in all respects), and shall
be true and correct in all material respects on and as of the Closing Date (unless they specifically speak as of another date
in which case they shall be true and correct in all material respects as of such date) (other than representations and warranties
that are qualified as to materiality or Issuer Material Adverse Effect, which representations and warranties shall be true and
correct in all

 

    13 

     

    

respects)
with the same force and effect as if they had been made on and as of said date, but in each case without giving effect to consummation
of the Transactions.

 

3.3.2.       Compliance
with Covenants. The Issuer shall have performed, satisfied and complied in all material respects with the covenants, agreements
and conditions required by this Subscription Agreement to be performed, satisfied or complied with by the Issuer at or prior to
the Closing, except where the failure of such performance or compliance would not or would not reasonably be expected to prevent,
materially delay, or materially impair the ability of the Issuer to consummate the Closing.

 

3.3.3.       Closing
of the Transactions. All conditions precedent to the consummation of the Transactions set forth in the Business Combination
Agreement shall have been satisfied or waived by the party entitled to the benefit thereof under the Business Combination Agreement
(other than those conditions that may only be satisfied at the consummation of the Transactions, but subject to satisfaction or
waiver by such party of such conditions as of the consummation of the Transactions), and the Transactions will be consummated
immediately following the Closing.

 

3.3.4.       Legality.
There shall not be in force any order, judgment, injunction, decree, writ, stipulation, determination or award, in each case,
entered by or with any governmental authority, statute, rule or regulation enjoining or prohibiting consummation of the transactions
contemplated by this Subscription Agreement or the Transactions and no such governmental authority shall have instituted or threatened
in writing a proceeding seeking to impose any such restraint or prohibition (except in the case of a governmental authority located
outside the United States where such restraint or prohibition would not be reasonably expected to result in in Issuer Material
Adverse Effect)..

 

3.3.5.        Amendment
of Business Combination Agreement. The terms of the Business Combination Agreement shall not have been amended in a manner
that would reasonably be expected to materially and adversely affect the economic benefits that Subscriber (in its capacity as
such) would reasonably expect to receive under this Subscription Agreement in a manner disproportionate to other stockholders
of the Issuer unless the Subscriber has consented in writing to such amendment.

 

3.3.6.       Listing.
No suspension of the qualification of the Common Shares for offering or sale or trading in any jurisdiction, and no suspension
or removal from listing of the Common Shares on the NYSE or Nasdaq, and no initiation or threatening of any proceedings for any
of such purposes or delisting, shall have occurred, and the Subscribed Shares shall be approved for listing on the NYSE or Nasdaq,
as applicable, subject to official notice of issuance.

 

4.       Registration
Statement.

 

4.1.       The
Issuer agrees that, within thirty (30) calendar days after the consummation of the Transactions (the “Filing Date”),
the Issuer will file with the Commission (at the Issuer’s sole cost and expense) a registration statement (the “Registration
Statement”)

 

    14 

     

    

registering
the resale of the Subscribed Shares (the “Registrable Securities”), and the Issuer shall use its commercially
reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof, but
no later than the earlier of (i) the 60th calendar day (or 90th calendar day if the Commission notifies the Issuer that it will
“review” the Registration Statement) following the Closing Date and (ii) the 5th Business Day after the date the Issuer
is notified (orally or in writing, whichever is earlier) by the Commission that the Registration Statement will not be “reviewed”
or will not be subject to further review (such earlier date, the “Effectiveness Date”); provided, however,
that the Issuer’s obligations to include the Registrable Securities in the Registration Statement are contingent upon Subscriber
furnishing a completed and executed selling shareholders questionnaire in customary form to the Issuer that contains the information
required by Commission rules for a Registration Statement regarding Subscriber, the securities of the Issuer held by Subscriber
and the intended method of disposition of the Registrable Securities to effect the registration of the Registrable Securities,
and Subscriber shall execute such documents in connection with such registration as the Issuer may reasonably request that are
customary of a selling stockholder in similar situations, including providing that the Issuer shall be entitled to postpone and
suspend the effectiveness or use of the Registration Statement, if applicable, as permitted hereunder; provided, that Subscriber
shall not in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise be subject to
any contractual restriction on the ability to transfer the Registrable Securities. For purposes of clarification, any failure
by the Issuer to file the Registration Statement by the Filing Date or to effect such Registration Statement by the Effectiveness
Date shall not otherwise relieve the Issuer of its obligations to file or effect the Registration Statement as set forth above
in this Section ‎4. For purposes of this Section ‎4, Registrable Securities shall include,
as of any date of determination, the Subscribed Shares and any other equity security of the Issuer issued or issuable with respect
to the Subscribed Shares by way of share split, dividend, distribution, recapitalization, merger, exchange, replacement or similar
event or otherwise. The Issuer will provide a draft of the Registration Statement to Subscriber for review at least two (2) business
days in advance of filing the Registration Statement. In no event shall Subscriber be identified as a statutory underwriter in
the Registration Statement unless requested by the Commission. Notwithstanding the foregoing, if the Commission prevents the Issuer
from including any or all of the Subscribed Shares proposed to be registered for resale under the Registration Statement due to
limitations on the use of Rule 415 of the Securities Act for the resale of the Subscribed Shares by the applicable shareholders
or otherwise, (i) such Registration Statement shall register for resale such number of Subscribed Shares which is equal to the
maximum number of Subscribed Shares as is permitted by the Commission and (ii) the number of Subscribed Shares to be registered
for each selling shareholder named in the Registration Statement shall be reduced pro rata among all such selling shareholders;
and as promptly as practicable after being permitted to register additional Subscribed Shares under Rule 415 under the Securities
Act, the Issuer shall amend the Registration Statement or file a new Registration Statement to register such Subscribed Shares
not included in the initial Registration Statement and cause such amendment or Registration Statement to become effective as promptly
as practicable.

 

4.2.       In
the case of the registration effected by the Issuer pursuant to this Subscription Agreement, the Issuer shall, upon reasonable
request, inform Subscriber as to the status of such registration. At its expense the Issuer shall:

 

    15 

     

    

4.2.1.       except
for such times as the Issuer is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement,
use its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state
securities laws which the Issuer determines to obtain, continuously effective with respect to Subscriber, and to keep the applicable
Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions, until the
earlier of the following: (i) Subscriber ceases to hold any Registrable Securities and (ii) the date all Registrable Securities
held by Subscriber may be sold without restriction under Rule 144, including without limitation, any volume and manner of sale
restrictions which may be applicable to affiliates under Rule 144 and without the requirement for the Issuer to be in compliance
with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable);

 

4.2.2.       advise
Subscriber, as promptly as practicable but in any event within three (3) Business Days:

 

(a)       when
a Registration Statement or any post-effective amendment thereto has become effective;

 

(b)       of
the issuance by the Commission of any stop order suspending the effectiveness of any Registration Statement or the initiation
of any proceedings for such purpose;

 

(c)       of
the receipt by the Issuer of any notification with respect to the suspension of the qualification of the Registrable Securities
included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and

 

(d)       subject
to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in any
Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state
a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the
light of the circumstances under which they were made) not misleading.

 

Notwithstanding
anything to the contrary set forth herein, the Issuer shall not, when so advising Subscriber of such events, provide Subscriber
with any material, nonpublic information regarding the Issuer other than to the extent that providing notice to Subscriber of
the occurrence of the events listed in (a) through (d) above constitutes material, nonpublic information regarding the Issuer;

 

4.2.3.       use
its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement
as soon as reasonably practicable;

 

    16 

     

    

4.2.4.       upon
the occurrence of any event contemplated in Section ‎4.2.2(d), except for such times as the Issuer is permitted
hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Issuer shall use
its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration
Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers
of the Registrable Securities included therein, such prospectus will not include any untrue statement of a material fact or omit
to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading; and

 

4.2.5.       use
its commercially reasonable efforts to cause all Subscribed Shares to be listed on each securities exchange or market, if any,
on which the Issuer’s common stock is then listed.

 

4.2.6.       (a)
use its commercially reasonable efforts to cause the removal of the restrictive legends from (i) any Subscribed Shares being sold
under the Registration Statement, (ii) at the time of sale of such Registrable Securities pursuant to Rule 144 and (iii) at the
request of a Holder (defined below) at such time as any Registrable Securities held by such Holder may be sold by such Holder
without restriction under Rule 144, including without limitation, any volume and manner of sale restrictions, and (b) request
its legal counsel to deliver an opinion, if necessary, to the transfer agent to the effect that the removal of such restrictive
legends in such circumstances may be effected under the Securities Act, in each case upon the receipt of customary representations
and other documentation, if any, from the Holder as reasonably requested by the Issuer, its counsel or the transfer agent, establishing
that restrictive legends are no longer required. “Holder” shall mean Subscriber or any affiliate of Subscriber to
which the rights under this Section 4 shall have been assigned.

 

4.3.       Notwithstanding
anything to the contrary in this Subscription Agreement, the Issuer shall be entitled to delay or postpone the effectiveness of
the Registration Statement, and from time to time to require Subscriber not to sell under the Registration Statement or to suspend
the effectiveness thereof, (i) as may be necessary in connection with the preparation and filing of a post-effective amendment
to the Registration Statement following the filing of the Issuer’s Annual Report on Form 10-K, or (ii) if the filing, effectiveness
or continued use of any Registration Statement would require the Issuer to make any public disclosure of material non-public information,
which disclosure, in the good faith determination of the board of directors of the Issuer, after consultation with counsel to
the Issuer, (a) would be required to be made in any Registration Statement in order for the applicable Registration Statement
not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained
therein not misleading, (b) would not be required to be made at such time if the Registration Statement were not being filed,
and (c) the Issuer has a bona fide business purpose for not making such information public (each such circumstance, a “Suspension
Event”); provided, however, that the Issuer may not delay or suspend the Registration Statement on more
than two occasions or for more than sixty (60) consecutive calendar days, or more than ninety (90) total calendar days, in each
case during any twelve-month period. Upon receipt of

 

    17 

     

    

any written
notice from the Issuer of the happening of any Suspension Event during the period that the Registration Statement is effective
or if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement of a material
fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made (in the case of the prospectus) not misleading, Subscriber agrees that (i) it will
immediately discontinue offers and sales of the Subscribed Shares under the Registration Statement (excluding, for the avoidance
of doubt, sales conducted pursuant to Rule 144) until Subscriber receives copies of a supplemental or amended prospectus (which
the Issuer agrees to promptly prepare) that corrects the misstatement(s) or omission(s) referred to above and receives notice
that any post-effective amendment has become effective or unless otherwise notified by the Issuer that it may resume such offers
and sales, and (ii) it will maintain the confidentiality of any information included in such written notice delivered by the Issuer
except (A) for disclosure to Subscriber’s employees, agents and professional advisers who need to know such information
and are obligated to keep it confidential, (B) for disclosures to the extent required in order to comply with reporting obligations
to its limited partners who have agreed to keep such information confidential and (C) as required by law. If so directed by the
Issuer, Subscriber will deliver to the Issuer or, in Subscriber’s sole discretion destroy, all copies of the prospectus
covering the Subscribed Shares in Subscriber’s possession; provided, however, that this obligation to deliver
or destroy all copies of the prospectus covering the Subscribed Shares shall not apply (i) to the extent Subscriber is required
to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory, self-regulatory or professional
requirements or (b) in accordance with a bona fide pre-existing document retention policy or (ii) to copies stored electronically
on archival servers as a result of automatic data back-up.

 

4.4.       Subscriber
may deliver written notice (including via email in accordance with Section 6.3 (an “Opt-Out Notice”)
to the Issuer requesting that Subscriber not receive notices from the Issuer otherwise required by Section 4.3; provided, however,
that Subscriber may later revoke any such Opt-Out Notice in writing. Following receipt of an Opt-Out Notice
from Subscriber (unless subsequently revoked), (i) the Issuer shall not deliver any such notices to Subscriber and Subscriber
shall no longer be entitled to the rights associated with any such notice and (ii) each time prior to Subscriber’s
intended use of an effective Registration Statement, Subscriber will notify the Issuer in writing at least two (2) business
days in advance of such intended use, and if a notice of a Suspension Event was previously delivered (or would have been delivered
but for the provisions of this Section 4.4) and the related suspension period remains in effect, the Issuer will
so notify Subscriber, within one (1) business day of Subscriber’s notification to the Issuer, by delivering to Subscriber
a copy of such previous notice of Suspension Event, and thereafter will provide Subscriber with the related notice of the conclusion
of such Suspension Event immediately upon its availability.

 

4.5.       The
parties agree that:

 

4.5.1.       The
Issuer shall, not withstanding the termination of this Subscription Agreement, indemnify and hold harmless, to the extent permitted
by law,

 

    18 

     

    

Subscriber
(to the extent a seller under the Registration Statement), the officers, directors, agents, partners, members, managers, shareholders,
affiliates, employees and investment advisers of each Subscriber, each person who controls such Subscriber (within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act), and the officers, directors, partners, members,
managers, shareholders, agents, affiliates, employees and investment advisers of each such controlling from and against any and
all out-of-pocket losses, claims, damages, liabilities, costs and expenses (including, without limitation, any reasonable attorneys’
fees and expenses incurred in connection with defending or investigating any such action or claim) (collectively, “Losses”),
as incurred, that arise out of or are based upon any untrue or alleged untrue statement of material fact contained in any Registration
Statement (or incorporated by reference therein), prospectus included in any Registration Statement or preliminary prospectus
or any amendment thereof or supplement thereto or arising out of or relating to any omission or alleged omission to state a material
fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or form of prospectus
or supplement thereto, in light of the circumstances under which they were made) not misleading, except insofar as the same are
caused by or contained in any information furnished in writing to the Issuer by or on behalf of Subscriber expressly for use therein
or Subscriber has omitted a material fact from such information; provided, however, that the indemnification contained in this
Section ‎4.5 shall not apply to amounts paid in settlement of any Losses if such settlement is effected without
the consent of the Issuer (which consent shall not be unreasonably withheld, conditioned or delayed), nor shall the Issuer be
liable for any Losses to the extent they arise out of or are based upon a violation which occurs (A) in reliance upon and in conformity
with written information furnished by Subscriber, (B) in connection with any failure of such person to deliver or cause to be
delivered a prospectus made available by the Issuer in a timely manner, (C) as a result of offers or sales effected by or on behalf
of any person by means of a “free writing prospectus” (as defined in Rule 405 under the Securities Act) that was not
authorized in writing by the Issuer, or (D) in connection with any offers or sales effected by or on behalf of Subscriber in violation
of Section ‎4.3 hereof. The Issuer shall notify Subscriber promptly of the institution, threat or assertion
of any proceeding arising from or in connection with the transactions contemplated by this Section ‎4 of which
the Issuer is aware.

 

4.5.2.       Subscriber
agrees, severally and not jointly with any person that is a party to the Other Subscription Agreements, to indemnify and hold
harmless, to the extent permitted by law, the Issuer, its directors, officers, employees and agents and each person who controls
the Issuer (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act) against any and all Losses,
as incurred, that arise out of or are based upon any untrue or alleged untrue statement of material fact contained in any Registration
Statement, prospectus included in any Registration Statement or preliminary prospectus or any amendment thereof or supplement
thereto or arising out of or relating to any omission of a material fact required to be stated therein or necessary to make the
statements therein (in the case of any prospectus or form of prospectus or supplement thereto, in light of the circumstances under
which they were made) not misleading, but only to the extent that such untrue statement or omission is contained in

 

    19 

     

    

any
information or affidavit so furnished in writing by such Subscriber expressly for use therein; provided, however,
that the indemnification contained in this Section ‎4.5 shall not apply to amounts paid in settlement of any
Losses if such settlement is effected without the consent of Subscriber (which consent shall not be unreasonably withheld, conditioned
or delayed). Notwithstanding anything to the contrary herein, in no event shall the liability of Subscriber be greater in amount
than the dollar amount of the net proceeds received by Subscriber upon the sale of the Subscribed Shares purchased pursuant to
this Subscription Agreement giving rise to such indemnification obligation.

 

4.5.3.       Any
person entitled to indemnification herein shall (1) give prompt written notice to the indemnifying party of any claim with respect
to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to
indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (2) permit such indemnifying
party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed,
the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent.
An indemnifying party who elects not to assume the defense of a claim shall not be obligated to pay the fees and expenses of more
than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment
of legal counsel to any indemnified party a conflict of interest exists between such indemnified party and any other of such indemnified
parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party (which consent shall
not be unreasonably withheld, conditioned or delayed), consent to the entry of any judgment or enter into any settlement which
cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the
terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or
plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

4.5.4.       The
indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation
made by or on behalf of the indemnified party and shall survive the transfer of the Subscribed Shares purchased pursuant to this
Subscription Agreement.

 

4.5.5.       If
the indemnification provided under this Section ‎4.5 from the indemnifying party is unavailable or insufficient
to hold harmless an indemnified party in respect of any Losses referred to herein, then the indemnifying party, in lieu of indemnifying
the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims,
damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party
and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue
or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates
to information supplied by, such indemnifying party or

 

    20 

     

    

indemnified
party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and
opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the Losses or other liabilities
referred to above shall be deemed to include, subject to the limitations set forth above, any legal or other fees, charges or
expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this
Section ‎4.5 from any person who was not guilty of such fraudulent misrepresentation. In no event shall the
liability of Subscriber be greater in amount than the dollar amount of the net proceeds received by Subscriber upon the sale of
the Subscribed Shares purchased pursuant to this Subscription Agreement giving rise to such contribution obligation.

 

5.       Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of
the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest
to occur of (i) such date and time as the Business Combination Agreement is validly terminated in accordance with its terms, (ii)
upon the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement and (iii) at the election
of Subscriber after September 30, 2021 if the Closing shall not have occurred; provided that nothing herein will relieve
any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any
remedies at law or in equity to recover losses, liabilities or damages arising from such breach. The Issuer shall promptly notify
Subscriber of the termination of the Business Combination Agreement promptly after the termination of such agreement.

 

6.       Miscellaneous.

 

6.1.       Further
Assurances. At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional
actions as the parties reasonably may deem to be practical and necessary in order to consummate the Subscription as contemplated
by this Subscription Agreement.

 

6.1.1.       Subscriber
acknowledges that the Issuer will rely on the acknowledgments, understandings, agreements, representations and warranties made
by Subscriber contained in this Subscription Agreement. Prior to the Closing, Subscriber agrees to promptly notify the Issuer
if any of the acknowledgments, understandings, agreements, representations and warranties made by Subscriber set forth herein
are no longer accurate in all material respects. The Issuer acknowledges that Subscriber will rely on the acknowledgments, understandings,
agreements, representations and warranties made by the Issuer contained in this Subscription Agreement.

 

6.1.2.       Each
of the Issuer and Subscriber is entitled to rely upon this Subscription Agreement and is irrevocably authorized to produce this
Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry
with respect to the matters covered hereby.

 

    21 

     

    

6.1.3.       The
Issuer may request from Subscriber such additional information as the Issuer may reasonably deem necessary to evaluate the eligibility
of Subscriber to acquire the Subscribed Shares, and Subscriber shall provide such information as may be reasonably requested,
to the extent within Subscriber’s possession and control or otherwise readily available to Subscriber, provided that the
Issuer agrees to keep confidential any such information provided by Subscriber.

 

6.1.4.       Each
of Subscriber and the Issuer shall pay all of its own respective expenses in connection with this Subscription Agreement and the
transactions contemplated herein (it being agreed that all expenses related to the Registration Statement are for the account
of the Issuer to the extent provided in Section 4).

 

6.1.5.       Each
of Subscriber and the Issuer shall take, or cause to be taken, all actions and do, or cause to be done, all things necessary,
proper or advisable to consummate the transactions contemplated by this Subscription Agreement on the terms and conditions described
therein no later than immediately prior to the consummation of the Transactions.

 

6.2.       Subscriber
hereby acknowledges and agrees that, except in respect of any stock lending program, it will not, nor will any person acting at
Subscriber’s direction or pursuant to any understanding with Subscriber (including Subscriber’s controlled affiliates),
directly or indirectly, offer, sell, pledge, contract to sell, sell any option in, or engage in hedging activities or execute
any “short sales” (as defined in Rule 200 of Regulation SHO under the Exchange Act) with respect to, any Subscribed
Shares or any securities of the Issuer or any instrument exchangeable for or convertible into any Subscribed Shares or any securities
of the Issuer until the consummation of the Transactions (or such earlier termination of this Subscription Agreement in accordance
with its terms). Notwithstanding the foregoing, (i) nothing herein shall prohibit any entities under common management with Subscriber
that have no knowledge of this Subscription Agreement or of Subscriber’s participation in the transactions contemplated
hereby (including Subscriber’s controlled affiliates and/or affiliates) from entering into any short sales; (ii) in the
case of a Subscriber that is a multimanaged investment vehicle whereby separate portfolio managers manage separate portions of
such Subscriber’s assets and the portfolio managers have no knowledge of the investment decisions made by the portfolio
managers managing other portions of such Subscriber’s assets, this Section 6.2 shall only apply with respect to the
portion of assets managed by the portfolio manager that made the investment decision to purchase the Subscribed Shares covered
by this Subscription Agreement.

 

6.3.       Notices.
Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or sent
by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed
to be given and received (i) when so delivered personally, (ii) when sent, with no mail undeliverable or other rejection notice,
if sent by email, or (iii) three (3) Business Days after the date of mailing to the address below or to such other address or
addresses as such person may hereafter designate by notice given hereunder:

 

    22 

     

    

(i) if to Subscriber,
to such address or addresses set forth on the signature page hereto;

 

(ii) if to
the Issuer, to:

 

VG Acquisition Corp.

65 Bleecker Street, 6th
Floor

New York, NY

Attention:General
Counsel

Email:        james.cahillane@virgin.com

 

with a required
copy (which copy shall not constitute notice) to:

 

Davis Polk & Wardwell
LLP

450 Lexington Avenue

New York, NY 10017

Attention:Derek Dostal,
Lee Hochbaum, William Aaronson

Email:        derek.dostal@davispolk.com

   lee.hochbaum@davispolk.com

  william.aaronson@davispolk.com

 

6.4.       Entire
Agreement. This Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings,
representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof, including
any commitment letter entered into relating to the subject matter hereof.

 

6.5.       Modifications
and Amendments. This Subscription Agreement may not be amended, modified, supplemented or waived except by an instrument in
writing, signed by the party against whom enforcement of such amendment, modification, supplement or waiver is sought (and in
the case where the Issuer’s consent is required, also signed by 23andMe).

 

6.6.       Assignment.
Neither this Subscription Agreement nor any rights, interests or obligations that may accrue to the parties hereunder (including
Subscriber’s rights to purchase the Subscribed Shares) may be transferred or assigned without the prior written consent
of the Issuer; provided that Subscriber’s rights and obligations hereunder may be assigned to any fund or account managed
by the same investment manager as Subscriber, without the prior consent of the Issuer, provided that such assignee(s) agrees in
writing to be bound by the terms hereof, and upon such assignment by a Subscriber, the assignee(s) shall become Subscriber hereunder
and have the rights and obligations and be deemed to make the representations and warranties of Subscriber provided for herein
to the extent of such assignment; provided further that, no assignment shall relieve the assigning party of any of its
obligations hereunder, including any assignment to any fund or account managed by the same investment manager as Subscriber.

 

6.7.       Benefit.
Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties
hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements,
representations, warranties, covenants and acknowledgments contained herein shall be deemed to

 

    23 

     

    

be made by,
and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns. This Subscription
Agreement shall not confer rights or remedies upon any person other than the parties hereto and their respective successors and
assigns, except that the Placement Agents shall be third-party beneficiaries to the representations and warranties made by the
Issuer and Subscriber in this Subscription Agreement.

 

6.8.       Governing
Law. This Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this
Subscription Agreement (whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution,
performance or enforcement of this Subscription Agreement, shall be governed by and construed in accordance with the laws of the
State of Delaware, without giving effect to the principles of conflicts of law thereof.

 

6.9.       Consent
to Jurisdiction; Waiver of Jury Trial. Each of the parties irrevocably consents to the exclusive jurisdiction and venue of
the Court of Chancery of the State of Delaware, provided that if subject matter jurisdiction over the matter that is the subject
of the legal proceeding is vested exclusively in the U.S. federal courts, such legal proceeding shall be heard in the U.S. District
Court for the District of Delaware (together with the Court of Chancery of the State of Delaware, “Chosen Courts”),
in connection with any matter based upon or arising out of this Subscription Agreement. Each party hereby waives, and shall not
assert as a defense in any legal dispute, that (i) such person is not personally subject to the jurisdiction of the Chosen Courts
for any reason, (ii) such legal proceeding may not be brought or is not maintainable in the Chosen Courts, (iii) such person’s
property is exempt or immune from execution, (iv) such legal proceeding is brought in an inconvenient forum or (v) the venue of
such legal proceeding is improper. Each party hereby consents to service of process in any such proceeding in any manner permitted
by Delaware law, further consents to service of process by nationally recognized overnight courier service guaranteeing overnight
delivery, or by registered or certified mail, return receipt requested, at its address specified pursuant to Section ‎6.3
and waives and covenants not to assert or plead any objection which they might otherwise have to such manner of service of
process. Notwithstanding the foregoing in this Section ‎6.9, a party may commence any action, claim, cause of
action or suit in a court other than the Chosen Courts solely for the purpose of enforcing an order or judgment issued by the
Chosen Courts. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH OF THE PARTIES WAIVES ANY RIGHT TO
TRIAL BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT WHETHER NOW
EXISTING OR HEREAFTER ARISING. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED,
NO PARTY SHALL ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT.
FURTHERMORE, NO PARTY SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH
A JURY TRIAL CANNOT BE WAIVED.

 

6.10.       Severability.
If any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability
of the remaining

 

    24 

     

    

provisions
of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.

 

6.11.       No
Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under
this Subscription Agreement, and no course of dealing between the parties hereto, shall operate as a waiver of any such right,
power or remedy of such party. No single or partial exercise of any right, power or remedy under this Subscription Agreement by
a party hereto, nor any abandonment or discontinuance of steps to enforce any such right, power or remedy, shall preclude such
party from any other or further exercise thereof or the exercise of any other right, power or remedy hereunder. The election of
any remedy by a party hereto shall not constitute a waiver of the right of such party to pursue other available remedies. No notice
to or demand on a party not expressly required under this Subscription Agreement shall entitle the party receiving such notice
or demand to any other or further notice or demand in similar or other circumstances or constitute a waiver of the rights of the
party giving such notice or demand to any other or further action in any circumstances without such notice or demand.

 

6.12.       Remedies.

 

6.12.1.       The
parties agree that irreparable damage would occur if this Subscription Agreement is not performed or the Closing is not consummated
in accordance with its specific terms or is otherwise breached and that money damages or other legal remedies would not be an
adequate remedy for any such damage. It is accordingly agreed that the parties hereto shall be entitled to equitable relief, including
in the form of an injunction or injunctions, to prevent breaches or threatened breaches of this Subscription Agreement and to
enforce specifically the terms and provisions of this Subscription Agreement in an appropriate court of competent jurisdiction
as set forth in Section ‎6.9, this being in addition to any other remedy to which any party is entitled at law
or in equity, including money damages. The right to specific enforcement shall include the right of the parties hereto to cause
the other parties hereto to cause the transactions contemplated hereby to be consummated on the terms and subject to the conditions
and limitations set forth in this Subscription Agreement. The parties hereto further agree (i) to waive any requirement for the
security or posting of any bond in connection with any such equitable remedy, (ii) not to assert that a remedy of specific enforcement
pursuant to this Section ‎6.12 is unenforceable, invalid, contrary to applicable law or inequitable for any
reason and (iii) to waive any defenses in any action for specific performance, including the defense that a remedy at law would
be adequate.

 

6.12.2.       The
parties acknowledge and agree that this Section ‎6.12 is an integral part of the transactions contemplated hereby
and without that right, the parties hereto would not have entered into this Subscription Agreement.

 

6.13.       Survival
of Representations and Warranties and Covenants. All representations and warranties made by the parties hereto, and all covenants
and other agreements of the parties hereto, in this Subscription Agreement shall survive the Closing. For the avoidance of doubt,
if for any reason the Closing does not occur prior to the consummation

 

    25 

     

    

of the Transactions,
all representations, warranties, covenants and agreements of the parties hereunder shall survive the consummation of the Transactions
and remain in full force and effect.

 

6.14.       Headings
and Captions. The headings and captions of the various subdivisions of this Subscription Agreement are for convenience of
reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.

 

6.15.       Counterparts.
This Subscription Agreement may be executed in one or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
parties, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission or any other form of electronic delivery, such signature shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page
were an original thereof.

 

6.16.       Construction.
The words “include,” “includes,” and “including” will be deemed to be
followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include
any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise
requires. The words “this Subscription Agreement,” “herein,” “hereof,”
“hereby,” “hereunder,” and words of similar import refer to this Subscription Agreement
as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation,
warranty, and covenant contained herein will have independent significance. If any party hereto has breached any representation,
warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant
relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached
will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant.
All references in this Subscription Agreement to numbers of shares, per share amounts and purchase prices shall be appropriately
adjusted to reflect any stock split, stock dividend, stock combination, recapitalization or the like occurring after the date
hereof.

 

6.17.       Mutual
Drafting. This Subscription Agreement is the joint product of the parties hereto and each provision hereof has been subject
to the mutual consultation, negotiation and agreement of the parties and shall not be construed for or against any party hereto.

 

7.       Cleansing
Statement; Disclosure.

 

7.1.       The
Issuer shall, by 9:00 a.m., New York City time, on the first (1st) Business Day immediately following the date of this Subscription
Agreement, issue one or more press releases or file with the Commission a Current Report on Form 8-K (collectively, the “Disclosure
Document”) disclosing all material terms of the transactions contemplated hereby and by the Other Subscription Agreements
and the Transactions and any other material nonpublic information that the Issuer or its officers, directors, employees or agents
has provided to Subscriber prior to the filing of the Disclosure Document. Upon the issuance of the Disclosure

 

    26 

     

    

Document, to
the actual knowledge of the Issuer, Subscriber shall not be in possession of any material, non-public information received from
the Issuer or any of its officers, directors, employees or agents, and Subscriber shall no longer be subject to any confidentiality
or similar obligations under any current agreement, whether written or oral, with the Issuer, the Placement Agents or any of their
respective affiliates, relating to the transactions contemplated by this Subscription Agreement.

 

7.2.       The
Issuer shall not (and shall cause its officers, directors, employees and agents not to) publicly disclose the name of Subscriber
or any affiliate or investment adviser of Subscriber, or include the name of Subscriber or any affiliate or investment adviser
of Subscriber without the prior written consent (including by e-mail) of Subscriber (i) in any press release or marketing materials,
or (ii) in any filing with the Commission or any regulatory agency or trading market, except as required by the federal securities
laws, rules or regulations and to the extent such disclosure is required by other laws, rules or regulations, at the request of
the staff of the Commission or regulatory agency or under regulations of the NYSE, in which case the Issuer shall provide Subscriber
with prior written notice (including by e-mail) of such permitted disclosure, and shall reasonably consult with Subscriber regarding
such disclosure.

 

8.       Trust
Account Waiver. In addition to the waiver of the Issuer pursuant to Section 7.03 of the Business Combination Agreement, and
notwithstanding anything to the contrary set forth herein, each of the Issuer and Subscriber acknowledges that the Issuer has
established a trust account containing the proceeds of its initial public offering and from certain private placements (collectively,
with interest accrued from time to time thereon, the “Trust Account”). Each of the Issuer and Subscriber agrees
that (i) it has no right, title, interest or claim of any kind in or to any monies held in the Trust Account, and (ii) it shall
have no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies
in, the Trust Account, in each case in connection with this Subscription Agreement, and hereby irrevocably waives any Claim to,
or to any monies in, the Trust Account that it may have in connection with this Subscription Agreement; provided, however,
that nothing in this Section ‎8 shall be deemed to limit Subscriber’s right, title, interest or claim
to the Trust Account by virtue of such Subscriber’s record or beneficial ownership of securities of the Issuer, including,
but not limited to, any redemption right with respect to any such securities of the Issuer. In the event Subscriber has any Claim
against the Issuer under this Subscription Agreement, Subscriber shall pursue such Claim solely against the Issuer and its assets
outside the Trust Account and not against the property or any monies in the Trust Account. Subscriber agrees and acknowledges
that such waiver is material to this Subscription Agreement and has been specifically relied upon by the Issuer to induce the
Issuer to enter into this Subscription Agreement and Subscriber further intends and understands such waiver to be valid, binding
and enforceable under applicable law.

 

9.       Non-Reliance.
Subscriber acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by
any person, firm or corporation, other than the representations and warranties of the Issuer expressly set forth in this Subscription
Agreement or in the SEC Documents, in making its investment or decision to invest in the Issuer. Subscriber agrees that no Other
Subscriber pursuant to this Subscription Agreement or any other agreement related to the private placement of shares of the Issuer’s
capital stock (including the controlling persons, officers, directors, partners, agents or employees of any such Subscriber)

 

    27 

     

    

shall be liable
to any Other Subscriber pursuant to this Subscription Agreement or any other agreement related to the private placement of shares
of the Issuer’s capital stock for any action heretofore or hereafter taken or omitted to be taken by any of them in connection
with the purchase of the Subscribed Shares hereunder.

 

10.       Rule
144. From and after such time as the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or
regulation of the Commission that may allow Subscriber to sell securities of the Issuer to the public without registration are
available to holders of the Issuer’s shares of common stock and for so long as the Subscriber holds the Subscribed Shares,
the Issuer agrees to:

 

10.1.       make
and keep public information available, as those terms are understood and defined in Rule 144; and

 

10.2.       file
with the Commission in a timely manner all reports and other documents required of the Issuer under the Securities Act and the
Exchange Act so long as the Issuer remains subject to such requirements and the filing of such reports and other documents is
required for the applicable provisions of Rule 144.

 

If the Subscribed
Shares are eligible to be sold without restriction under, and without the Issuer being in compliance with the current public information
requirements of, Rule 144 under the Securities Act, then at Subscriber’s request, the Issuer will cause its transfer agent
to remove the applicable restrictive legend. In connection therewith, if required by the Issuer’s transfer agent, the Issuer
will promptly cause an opinion of counsel to be delivered to and maintained with its transfer agent, together with any other authorizations,
certificates and directions required by the transfer agent that authorize and direct the transfer agent to issue such Subscribed
Shares without any such legend; provided that, notwithstanding the foregoing, Issuer will not be required to deliver any
such opinion, authorization, certificate or direction if it reasonably believes that removal of the legend could result in or
facilitate transfers of securities in violation of applicable law.

 

11.       Massachusetts
Business Trust. If Subscriber is a Massachusetts Business Trust, a copy of the Agreement and Declaration of Trust of Subscriber
or any affiliate thereof is on file with the Secretary of State of the Commonwealth of Massachusetts and notice is hereby given
that the Subscription Agreement is executed on behalf of the trustees of Subscriber or any affiliate thereof as trustees and not
individually and that the obligations of the Subscription Agreement are not binding on any of the trustees, officers or stockholders
of Subscriber or any affiliate thereof individually but are binding only upon Subscriber or any affiliate thereof and its
assets and property.

 

[Signature
Page Follows]

 

    28 

     

    

IN WITNESS
WHEREOF, each of the Issuer and Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized
representative as of the date set forth below.

 

 

	 	 	 	VG ACQUISITION CORP.	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	By:	/s/
    	 
	 	 	 	 	Name:		 
	 	 	 	 	Title:		 
	 	 	 	 	 	 	 

 

 

	 

 

     

     

    

Accepted and agreed this 4th
day of February, 2021.

 

SUBSCRIBER:

 

	Signature of Subscriber:	 	Signature of Joint Subscriber, if applicable:
	By:	 	 	By:	 
	Name:	 	Name:
	Title:	 	Title:
	 	 	 	 	 

 

Date: February 4, 2021

 

	Name of Subscriber:	 	Name of Joint Subscriber, if applicable:
		 	 
	(Please print. Please indicate name and	 	(Please print. Please indicate name and
	Capacity of person signing above)	 	Capacity of person signing above)

	 

                                                            
	 	 
	Name in which securities are to be registered	 	 
	(if different from the name of Subscriber listed directly above):	 	 

Email Address:

 

If there are joint investors,
please check one:

 

☐
Joint Tenants with Rights of Survivorship

 

☐
Tenants-in-Common

 

☐
Community Property

 

	Subscriber’s EIN:	 	 	Joint Subscriber’s EIN:	 

	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	 	 	 

     

     

    

	City, State, Zip:	 	City, State, Zip:	 
	Attn:	 	Attn:	 
	Telephone No.: _________________________	 	Telephone No.: _____________________
	Facsimile No.: __________________________	 	Facsimile No.: ______________________
	 	 	 	 	 	 	 	 

Aggregate Number of Subscribed
Shares subscribed for:

 

_____________________________________________

 

Aggregate Purchase Price: $______________.

 

You must pay the Purchase Price
by wire transfer of U.S. dollars in immediately available funds, to be held in escrow until the Closing, to the account specified
by the Issuer in the Closing Notice.

 

     

     

    

SCHEDULE
I

 

ELIGIBILITY
REPRESENTATIONS OF SUBSCRIBER

 

A.       QUALIFIED
INSTITUTIONAL BUYER STATUS

 

(Please check
the applicable subparagraphs):

 

		1.	☐
                                         We are a “qualified institutional buyer”
                                         (as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities
                                         Act”) (a “QIB”)).

 

		2.	☐
                                         We are subscribing for the Subscribed Shares as
                                         a fiduciary or agent for one or more investor accounts, and each owner of such account
                                         is a QIB.

 

*** OR ***

 

		B.	INSTITUTIONAL ACCREDITED INVESTOR
                                         STATUS (Please check the applicable subparagraphs):

 

		1.	☐
                                         We are an “accredited investor” (within
                                         the meaning of Rule 501(a) under the Securities Act) or an entity in which all of the
                                         equity holders are accredited investors within the meaning of Rule 501(a) under the Securities
                                         Act, and have marked and initialed the appropriate box on the following page indicating
                                         the provision under which we qualify as an “accredited investor.”

 

		2.	☐
                                         We are not a natural person.

 

*** AND ***

 

C.       AFFILIATE
STATUS

 

(Please check
the applicable box) SUBSCRIBER:

 

☐is:

 

☐is
not:

 

an “affiliate”
(as defined in Rule 144 under the Securities Act) of the Issuer or acting on behalf of an affiliate of the Issuer.

 

This
page should be completed by Subscriber

and constitutes a part of the Subscription Agreement.

 

     

     

    

Rule 501(a) under the Securities
Act, in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below
listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale
of the securities to that person. Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s)
below which apply to Subscriber and under which Subscriber accordingly qualifies as an “accredited investor.”

 

		☐	Any
                                         bank as defined in section 3(a)(2) of the Securities Act, or any savings and loan association
                                         or other institution as defined in section 3(a)(5)(A) of the Securities Act whether acting
                                         in its individual or fiduciary capacity;

 

		☐	Any
                                         broker or dealer registered pursuant to section 15 of the Securities Exchange Act of
                                         1934, as amended;

 

		☐	Any
                                         insurance company as defined in section 2(a)(13) of the Securities Act;

 

		☐	Any
                                         investment company registered under the Investment Company Act of 1940, as amended (the
                                         “Investment Company Act”) or a business development company as defined
                                         in section 2(a)(48) of the Investment Company Act;

 

		☐	Any
                                         Small Business Investment Company licensed by the U.S. Small Business Administration
                                         under section 301(c) or (d) of the Small Business Investment Act of 1958, as amended;

 

		☐	Any
                                         plan established and maintained by a state, its political subdivisions, or any agency
                                         or instrumentality of a state or its political subdivisions, for the benefit of its employees,
                                         if such plan has total assets in excess of $5,000,000;

 

		☐	Any
                                         employee benefit plan within the meaning of the Employee Retirement Income Security Act
                                         of 1974, as amended (“ERISA”), if (i) the investment decision is made
                                         by a plan fiduciary, as defined in section 3(21) of ERISA, which is either a bank, a
                                         savings and loan association, an insurance company, or a registered investment adviser,
                                         (ii) the employee benefit plan has total assets in excess of $5,000,000 or, (iii) such
                                         plan is a self-directed plan, with investment decisions made solely by persons that are
                                         “accredited investors”;

 

		☐	Any
                                         private business development company as defined in section 202(a)(22) of the Investment
                                         Advisers Act of 1940, as amended;

 

		☐	Any
                                         (i) corporation, limited liability company or partnership, (ii) Massachusetts or similar
                                         business trust, or (iii) organization described in section 501(c)(3) of the Internal
                                         Revenue Code of 1986, as amended, not formed for the specific purpose of acquiring the
                                         securities offered, and with total assets in excess of $5,000,000;

 

     

     

    

		☐	Any
                                         director, executive officer, or general partner of the issuer of the securities being
                                         offered or sold, or any director, executive officer, or general partner of a general
                                         partner of that issuer;

 

		☐	Any
                                         natural person whose individual net worth, or joint net worth with that person’s
                                         spouse, exceeds $1,000,000. For purposes of calculating a natural person’s net
                                         worth: (a) the person’s primary residence shall not be included as an asset; (b)
                                         indebtedness that is secured by the person’s primary residence, up to the estimated
                                         fair market value of the primary residence at the time of the sale of securities, shall
                                         not be included as a liability (except that if the amount of such indebtedness outstanding
                                         at the time of sale of securities exceeds the amount outstanding sixty (60) days before
                                         such time, other than as a result of the acquisition of the primary residence, the amount
                                         of such excess shall be included as a liability); and (c) indebtedness that is secured
                                         by the person’s primary residence in excess of the estimated fair market value
                                         of the primary residence at the time of the sale of securities shall be included as a
                                         liability;

 

		☐	Any
                                         natural person who had an individual income in excess of $200,000 in each of the two
                                         most recent years or joint income with that person’s spouse in excess of $300,000
                                         in each of those years and has a reasonable expectation of reaching the same income level
                                         in the current year;

 

		☐	Any
                                         trust, with total assets in excess of $5,000,000, not formed for the specific purpose
                                         of acquiring the securities offered, whose purchase is directed by a sophisticated person
                                         as described in Section 230.506(b)(2)(ii) of Regulation D;

 

		☐	Any
                                         entity in which all of the equity owners are “accredited investors”;

 

		☐	Any
                                         natural person holding in good standing one or more professional certifications or designations
                                         or credentials from an accredited educational institution that the SEC has designated
                                         as qualifying an individual for accredited investor status, such as a General Securities
                                         Representative license (Series 7), a Private Securities Offerings Representative license
                                         (Series 82) and an Investment Adviser Representative license (Series 65);

 

		☐	Any
                                         “family office” as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers
                                         Act of 1940 which was not formed for the purpose of investing in the Company, has assets
                                         under management in excess of $5,000,000 and whose prospective investment is directed
                                         by a person who has such knowledge and experience in financial and business matters that
                                         such family office is capable of evaluating the merits and risks of the prospective investment;
                                         or

 

     

     

    

		☐	Any
                                         “family client,” as defined in rule 202(a)(11)(G)-1 under the Investment
                                         Advisers Act of 1940, of a family office, whose prospective investment in the Company
                                         is directed by such family office, and such family office is one (i) with assets under
                                         management in excess of $5,000,000, (ii) that was not formed for the specific purpose
                                         of investing in the Company, and (iii) whose prospective investment in the Company is
                                         directed by a person who has such knowledge and experience in financial and business
                                         matters that such family office is capable of evaluating the merits and risks of such
                                         prospective investment.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]